Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Pavel J Jedlicka

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Pathology
Phone303/724-8161

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jedlickov? V, Hejret V, Demko M, Jedlicka P, ?tefkov? M, Robert HS. Transcriptome analysis of thermomorphogenesis in ovules and during early seed development in Brassica napus. BMC Genomics. 2023 May 04; 24(1):236. PMID: 37142980.
      View in: PubMed
    2. Jedlicka P, Tokan V, Kejnovsk? I, Hobza R, Kejnovsk? E. Telomeric retrotransposons show propensity to form G-quadruplexes in various eukaryotic species. Mob DNA. 2023 Apr 10; 14(1):3. PMID: 37038191.
      View in: PubMed
    3. Tumova S, Milacek M, ?najdr I, Muthu M, Tuma R, Reha D, Jedlicka P, Bittova L, Novotna A, Majer P, Sedlak D, Jindra M. Unique peptidic agonists of a juvenile hormone receptor with species-specific effects on insect development and reproduction. Proc Natl Acad Sci U S A. 2022 11 29; 119(48):e2215541119. PMID: 36409882.
      View in: PubMed
    4. Lexa M, Cechova M, Nguyen SH, Jedlicka P, Tokan V, Kubat Z, Hobza R, Kejnovsky E. HiC-TE: a computational pipeline for Hi-C data analysis to study the role of repeat family interactions in the genome 3D organization. Bioinformatics. 2022 08 10; 38(16):4030-4032. PMID: 35781332.
      View in: PubMed
    5. Kejnovsky E, Jedlicka P. Nucleic acids movement and its relation to genome dynamics of repetitive DNA: Is cellular and intercellular movement of DNA and RNA molecules related to the evolutionary dynamic genome components?: Is cellular and intercellular movement of DNA and RNA molecules related to the evolutionary dynamic genome components? Bioessays. 2022 04; 44(4):e2100242. PMID: 35112737.
      View in: PubMed
    6. Koubov? J, Pangr?cov? M, Jank?sek M, Luk?an O, Jehl?k T, Brabcov? J, Jedlicka P, Kriv?nek J, Capkov? Frydrychov? R, Hanus R. Long-lived termite kings and queens activate telomerase in somatic organs. Proc Biol Sci. 2021 04 28; 288(1949):20210511. PMID: 33878922.
      View in: PubMed
    7. Tokan V, Rodriguez Lorenzo JL, Jedlicka P, Kejnovska I, Hobza R, Kejnovsky E. Quadruplex-Forming Motif Inserted into 3'UTR of Ty1his3-AI Retrotransposon Inhibits Retrotransposition in Yeast. Biology (Basel). 2021 Apr 20; 10(4). PMID: 33924086.
      View in: PubMed
    8. McCann TS, Parrish JK, Hsieh J, Sechler M, Sobral LM, Self C, Jones KL, Goodspeed A, Costello JC, Jedlicka P. KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma. Oncotarget. 2020 Oct 27; 11(43):3818-3831. PMID: 33196691.
      View in: PubMed
    9. Sobral LM, Hicks HM, Parrish JK, McCann TS, Hsieh J, Goodspeed A, Costello JC, Black JC, Jedlicka P. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma. Mol Oncol. 2020 10; 14(10):2471-2486. PMID: 32697014.
      View in: PubMed
    10. Sobral LM, Sechler M, Parrish JK, McCann TS, Jones KL, Black JC, Jedlicka P. KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma. Genes Cancer. 2020; 11(1-2):53-65. PMID: 32577157.
      View in: PubMed
    11. McCann TS, Sobral LM, Self C, Hsieh J, Sechler M, Jedlicka P. Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview. Expert Opin Ther Targets. 2019 04; 23(4):267-280. PMID: 30759030.
      View in: PubMed
    12. Parrish JK, McCann TS, Sechler M, Sobral LM, Ren W, Jones KL, Tan AC, Jedlicka P. The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth. Oncotarget. 2018 Sep 04; 9(69):33110-33123. PMID: 30237855.
      View in: PubMed
    13. Jedlicka P. The potential of KDM3A as a therapeutic target in Ewing Sarcoma and other cancers. Expert Opin Ther Targets. 2017 11; 21(11):997-999. PMID: 29022407.
      View in: PubMed
    14. Moore C, Parrish JK, Jedlicka P. MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth. PLoS One. 2017; 12(5):e0178028. PMID: 28542597.
      View in: PubMed
    15. Sechler M, Parrish JK, Birks DK, Jedlicka P. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis. Oncogene. 2017 07 20; 36(29):4150-4160. PMID: 28319067.
      View in: PubMed
    16. Niemeyer BF, Parrish JK, Spoelstra NS, Joyal T, Richer JK, Jedlicka P. Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes. PLoS One. 2015; 10(1):e0116895. PMID: 25603314.
      View in: PubMed
    17. Parrish JK, Sechler M, Winn RA, Jedlicka P. The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma. Oncogene. 2015 Jan 08; 34(2):257-62. PMID: 24362521.
      View in: PubMed
    18. Dylla L, Jedlicka P. Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma. PLoS One. 2013; 8(4):e63032. PMID: 23638178.
      View in: PubMed
    19. Dylla L, Moore C, Jedlicka P. MicroRNAs in Ewing Sarcoma. Front Oncol. 2013; 3:65. PMID: 23543617.
      View in: PubMed
    20. Robin TP, Smith A, McKinsey E, Reaves L, Jedlicka P, Ford HL. EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. Mol Cancer Res. 2012 Aug; 10(8):1098-108. PMID: 22723308.
      View in: PubMed
    21. McKinsey EL, Parrish JK, Irwin AE, Niemeyer BF, Kern HB, Birks DK, Jedlicka P. A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. Oncogene. 2011 Dec 08; 30(49):4910-20. PMID: 21643012.
      View in: PubMed
    22. Jedlicka P. Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. Int J Clin Exp Pathol. 2010 Mar 19; 3(4):338-47. PMID: 20490326.
      View in: PubMed
    Jedlicka's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (88) concept(s)
    _
    Co-Authors Expand Description
    See all (7) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)